Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
about
Bone Regeneration from PLGA Micro-NanoparticlesAn overview of clinical and commercial impact of drug delivery systemsParticulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogensDrug-nanoencapsulated PLGA microspheres prepared by emulsion electrospray with controlled release behavior.Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacyBiodegradable polymeric microsphere-based vaccines and their applications in infectious diseasesFunctional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice techniqueRobust IgG responses to nanograms of antigen using a biomimetic lipid-coated particle vaccine.Localized cell and drug delivery for auditory prostheses.Cell stimulation with optically manipulated microsourcesThe microclimate pH in poly(D,L-lactide-co-hydroxymethyl glycolide) microspheres during biodegradationClaudin 4-targeted protein incorporated into PLGA nanoparticles can mediate M cell targeted delivery.Optimization of stability, encapsulation, release, and cross-priming of tumor antigen-containing PLGA nanoparticles.Pulmonary immunization using antigen 85-B polymeric microparticles to boost tuberculosis immunity.Antigen delivery by lipid-enveloped PLGA microparticle vaccines mediated by in situ vesicle shedding.The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus.Mapping microclimate pH distribution inside protein-encapsulated PLGA microspheres using confocal laser scanning microscopyThe respiratory syncytial virus G protein conserved domain induces a persistent and protective antibody response in rodentsPoly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.Stabilization of tetanus toxoid encapsulated in PLGA microspheres.Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels.Novel PLA microspheres with hydrophilic and bioadhesive surfaces for the controlled delivery of fenretinide.Acetalated dextran is a chemically and biologically tunable material for particulate immunotherapy.Formulation and Characterization of Antigen-loaded PLGA Nanoparticles for Efficient Cross-priming of the AntigenSynthesis of a library of propargylated and PEGylated α-hydroxy acids toward "clickable" polylactides via hydrolysis of cyanohydrin derivatives.Sustained-release delivery of octreotide from biodegradable polymeric microspheres.Comparison of different delivery systems of DNA vaccination for the induction of protection against tuberculosis in mice and guinea pigs.Protective effect of recombinant staphylococcal enterotoxin A entrapped in polylactic-co-glycolic acid microspheres against Staphylococcus aureus infection.Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis.A combination dual-sized microparticle system modulates dendritic cells and prevents type 1 diabetes in prediabetic NOD mice.Acetalated Dextran Microparticulate Vaccine Formulated via Coaxial Electrospray Preserves Toxin Neutralization and Enhances Murine Survival Following Inhalational Bacillus Anthracis Exposure.Microparticle surface modifications targeting dendritic cells for non-activating applications.Strategies for DNA vaccine delivery.Current advances in sustained-release systems for parenteral drug delivery.Nanoparticle-aptamer bioconjugates for cancer targeting.Immunostimulatory colloidal delivery systems for cancer vaccines.Particulate delivery systems for vaccines: what can we expect?Materials that harness and modulate the immune system.Nanoparticles and microparticles as vaccine-delivery systems.Design opportunities for actively targeted nanoparticle vaccines.
P2860
Q26778233-F16137D4-AFF7-4ED5-AF16-C903AC01E000Q27007143-B3492F3F-E892-422E-99D1-7C0FF70E7410Q27011190-45EBF585-A16B-4C9C-AD4D-566319631CBFQ27321474-A3850E58-4C05-4F22-9648-0B0D3BFB7EE2Q27488746-87329A20-FCF6-4C50-8741-D3B9DD104D84Q28087409-8BA701FC-6102-45D0-9D4F-A4519497F171Q28535298-8DCCA501-C60A-47DB-89D9-2A9A672BC101Q30405708-7795F98A-4BAE-4748-8B8E-BE41AB7EFCD6Q30475885-438C3518-B835-4EAC-A653-72BF0E4AE8CCQ30492942-41A3E805-0237-4036-8D3B-0BCC2104FE4BQ31075222-B5AD8333-6A5E-4496-9082-849B3995082EQ33665038-54C5B785-956E-4BED-AC1D-28497ABFC52FQ33821392-9DD83A06-BF88-46B7-9E2F-26E9F24C2380Q33954601-8CB6E111-DBB4-42FC-93D4-74186BD6E8FDQ33972302-4422B11B-33A3-4FD5-A27C-26B12B1EAF2DQ34180779-E57FF395-76EE-48BE-85EB-C5C4E075896DQ34201279-4A0B7FB2-BEDF-4D49-9A78-05295C720DCCQ34222406-14022888-AC22-4BDC-AB59-2A82E5A5B566Q34455041-AB57017F-7EFE-4C2C-B3A6-D22C1C5088D5Q34722666-017A14C6-E225-4E1A-8F57-2B58144ADAFDQ34811820-1384DEA3-364B-481B-AF5E-D808A8D35F92Q34829200-4706DEFC-14D4-4A67-8951-7CD43DE02ABAQ34968934-EBE8B51A-FC56-4EF8-A6FB-DD8C431B14D3Q35157029-2B4A83C8-655A-41B5-89EB-D7A6441E1034Q35276655-F3B62ACA-A7F0-4BE2-BA9E-C534FF9A5EBDQ35577254-98E17C37-5C60-4C7C-AF2E-1EF4B44C7ED2Q35642403-615015FA-290E-490C-8305-5B77D424CDE2Q35963399-985DD528-5029-47BB-8681-3688B8E8417FQ35977996-783997DD-EAE6-4C62-943C-144350A1CF6FQ36011349-07092DD8-09C9-4BE0-B29D-3147FF82B891Q36122915-77C9FA9B-B610-4B66-8FF2-E797366E8072Q36191163-BF4DD787-E693-4BBA-9897-769E5E47D1BDQ36316818-5590731F-9D07-41B9-BDCE-359335ED8945Q36316931-D2E0B191-B03D-48BB-9283-FEEC64CE431BQ36460842-8E214EC5-764F-4FD4-BDD3-13B5DD4E0107Q36460849-462E9683-BAC0-417E-8AB1-699AAC4A16BCQ36492598-69FC4A91-7417-429B-87DF-2F680A718940Q36690859-319C25DC-21E9-459A-BA36-87586625BA08Q36968297-BA553348-F36E-45AD-A355-2BB5514561FDQ37062606-318105BC-3B8C-4986-A34F-EAFAAD47C36B
P2860
Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Biodegradable poly(lactic-co-g ...... delivery of vaccine antigens.
@ast
Biodegradable poly(lactic-co-g ...... delivery of vaccine antigens.
@en
type
label
Biodegradable poly(lactic-co-g ...... delivery of vaccine antigens.
@ast
Biodegradable poly(lactic-co-g ...... delivery of vaccine antigens.
@en
prefLabel
Biodegradable poly(lactic-co-g ...... delivery of vaccine antigens.
@ast
Biodegradable poly(lactic-co-g ...... delivery of vaccine antigens.
@en
P2093
P1476
Biodegradable poly(lactic-co-g ...... delivery of vaccine antigens.
@en
P2093
Mangesh C Deshpande
Rajesh K Gupta
Steven P Schwendeman
Wenlei Jiang
P304
P356
10.1016/J.ADDR.2004.09.003
P407
P577
2005-01-01T00:00:00Z